Draft rule offers 3 solutions for Medicare drug payments

Article Overview

This article discusses a CMS draft rule that outlines several approaches to Medicare Part B drug reimbursement, along with related payment adjustments and policy changes affecting physician practices. It is relevant to oncology practices, office-based clinicians, and coding/reimbursement professionals who follow Medicare payment policy, draft rulemaking, and drug reimbursement methodology. The article provides a high-level look at the types of reimbursement models under consideration, associated practice expense issues, and the anticipated impact on access to care, without providing the full regulatory text.